Deutsche Bank Ag\ Celularity Inc Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.42 - $0.81 $16,581 - $31,978	-39,480 Reduced 99.28%	287 $0
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $6,095 - $12,517	10,885 Added 37.69%	39,767 $24,000
Q4 2022 Feb 13, 2023	BUY	$1.08 - $2.35 $719 - $1,565	666 Added 2.36%	28,882 $37,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $7,356 - $73,735	17,108 Added 154.02%	28,216 $65,000
Q2 2022 Aug 11, 2022	BUY	$2.81 - $12.91 $31,213 - $143,404	11,108 New	11,108 $38,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $296M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.